Dopamine ameliorates hyperglycemic memory-induced microvascular dysfunction in diabetic retinopathy.

Area of Science:

• Ophthalmology
• Neuroscience
• Endocrinology

Background:

• Diabetic retinopathy (DR) is a leading cause of blindness, characterized by microvascular complications in the retina.
• The precise role of dopamine in retinal vascular dysfunction during DR is not well understood.
• Hyperglycemic memory (HGM) describes persistent cellular damage after blood glucose normalization in diabetes.

Purpose of the Study:

• To investigate the mechanism of HGM-induced retinal microvascular dysfunction in DR.
• To determine the protective effects of dopamine against HGM-induced retinal vascular abnormalities.
• To elucidate how dopamine influences oxidative stress and mitochondrial function in the context of DR.

Main Methods:

• Utilized mouse models of HGM and human retinal endothelial cells.
• Administered levodopa (a dopamine precursor) via intravitreal injection.
• Assessed markers of oxidative stress, mitochondrial integrity, adherens junction status, and vascular leakage.
• Evaluated pericyte degeneration, capillary abnormalities, and endothelial apoptosis.

Main Results:

• HGM induced persistent oxidative stress, mitochondrial dysfunction, and vascular leakage in mouse retinas, even after glucose normalization.
• Dopamine treatment and levodopa supplementation inhibited these HGM-induced detrimental effects.
• Levodopa ameliorated pericyte loss, acellular capillaries, and endothelial cell death in HGM mice.

Conclusions:

• Dopamine plays a protective role against HGM-induced retinal microvascular dysfunction in diabetic retinopathy.
• Dopamine alleviates retinal vascular leakage and abnormalities by mitigating persistent oxidative stress and mitochondrial dysfunction.
• Targeting dopamine pathways may offer a therapeutic strategy for managing diabetic retinopathy.